Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
7 hedge funds and large institutions have $4.36M invested in Forward Pharma A/S American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
22% less funds holding
Funds holding: 9 → 7 (-2)
25% less capital invested
Capital invested by funds: $5.85M → $4.36M (-$1.49M)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$12.8K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$8.09K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$296K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$179K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$141K |
| 4 |
Goldman Sachs
New York
|
-$105K |
| 5 |
HF
HRT Financial
New York
|
-$81K |
FWP Hedge Fund Activity: Q4 2021 in Review
7 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q4 2021, worth a combined $4.36M — down 25% from $5.85M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of FWP and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Osaic Holdings, adding an estimated $12.8K. The largest seller was Renaissance Technologies, cutting an estimated $296K.
- 7 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q4 2021, down from 9 in Q3 2021.
- Funds reported $4.36M of Forward Pharma A/S American Depositary Shares stock for Q4 2021, down 25% quarter-over-quarter.
- 1 fund opened new Forward Pharma A/S American Depositary Shares positions in Q4 2021 and 3 closed out, a net change of -2 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q4 2021 was Osaic Holdings, an estimated $12.8K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q4 2021 was Renaissance Technologies, an estimated $296K sold.
Based on aggregated 13F filings for Q4 2021.